ImmusanT Finds Celiac Disease Might Be Diagnosed With A Single Gluten Challenge
ImmusanT, a clinical-stage company developing Nexvax2®, a therapeutic vaccine intended to protect against the effects of gluten exposure while maintaining a gluten-free diet, presented data at the 2017 International Celiac Disease…
Continue Reading